These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs. Lang A; Vasar E; Soosaar A; Harro J Pharmacol Toxicol; 1992 Aug; 71(2):132-8. PubMed ID: 1332017 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice. Akhtar M; Uma Devi P; Ali A; Pillai KK; Vohora D Fundam Clin Pharmacol; 2006 Aug; 20(4):373-8. PubMed ID: 16867021 [TBL] [Abstract][Full Text] [Related]
9. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001 [TBL] [Abstract][Full Text] [Related]
10. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models. Pereira M; Siba IP; Chioca LR; Correia D; Vital MA; Pizzolatti MG; Santos AR; Andreatini R Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1636-44. PubMed ID: 21689712 [TBL] [Abstract][Full Text] [Related]
11. BMY-14802, a sigma ligand and potential antipsychotic drug, reverses amphetamine-induced changes in neostriatal single-unit activity in freely moving rats. Wang Z; Haracz JL; Rebec GV Synapse; 1992 Dec; 12(4):312-21. PubMed ID: 1361249 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors. Takahashi S; Sonehara K; Takagi K; Miwa T; Horikomi K; Mita N; Nagase H; Iizuka K; Sakai K Psychopharmacology (Berl); 1999 Aug; 145(3):295-302. PubMed ID: 10494578 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598). Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538 [TBL] [Abstract][Full Text] [Related]
14. Effects of NPC16377, a potent and selective sigma receptor ligand, on the activity of mesencephalic dopamine-containing neurons in the rat. Shepard PD; Lehmann H; Connelly ST Eur J Pharmacol; 1994 Nov; 265(3):141-9. PubMed ID: 7875229 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. Sorensen SM; Kehne JH; Fadayel GM; Humphreys TM; Ketteler HJ; Sullivan CK; Taylor VL; Schmidt CJ J Pharmacol Exp Ther; 1993 Aug; 266(2):684-91. PubMed ID: 8102646 [TBL] [Abstract][Full Text] [Related]
16. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats. Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological comparison of antipsychotic drugs and sigma-antagonists in rodents. Lang A; Soosaar A; Kõks S; Volke V; Bourin M; Bradwejn J; Vasar E Pharmacol Toxicol; 1994; 75(3-4):222-7. PubMed ID: 7800667 [TBL] [Abstract][Full Text] [Related]